Evidence map›Paper›PMID 31979394›Full record

ArticleInternational journal of molecular sciences2020

Low Dose of Penfluridol Inhibits VEGF-Induced Angiogenesis.

Suyash Srivastava, Fatema Tuz Zahra, Nehal Gupta, Paul E Tullar, Sanjay K Srivastava, Constantinos M Mikelis

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Suyash SrivastavaDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Fatema Tuz ZahraDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Nehal GuptaDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Paul E TullarDepartment of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Sanjay K SrivastavaDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Constantinos M MikelisDepartment of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Texas Tech University · US

Funding

Novel Class of Chemotherapeutic Agents for Treatment of Metastatic Triple-negative Breast CancerR15CA231339 · NCI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GERMAN, NADEZHDA A, MIKELIS, CONSTANTINOS MARIOS · 2018 to 2018
$459k
NIH HHS CA129038NIH HHS R15CA231339
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis InhibitorsAnimalsAntipsychotic AgentsBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationCell SurvivalCollagenDrug CombinationsFemaleHumansHuman Umbilical Vein Endothelial CellsLamininMiceMice, Inbred C57BLAngiogenesis InhibitorsAntipsychotic AgentsCollagenDrug CombinationsKDR protein, humanLamininmatrigelPenfluridolProteoglycansVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2VEGFA protein, humanangiogenesisbreast cancerpenfluridol

Identifiers

PMID31979394
PMCPMC7036977
OpenAlexW3000918087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.